Nicholas Wickham

1.1k total citations
35 papers, 804 citations indexed

About

Nicholas Wickham is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Nicholas Wickham has authored 35 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 16 papers in Genetics and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Nicholas Wickham's work include Chronic Lymphocytic Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Nicholas Wickham is often cited by papers focused on Chronic Lymphocytic Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Nicholas Wickham collaborates with scholars based in Australia, China and Hong Kong. Nicholas Wickham's co-authors include Margaret H.L. Ng, D. P. Huang, Kwok Wai Lo, Anna E. Schorer, Kathleen Watson, Alexander Gallus, Barry N J Walters, Harry S. Jacob, Wai Sang Poon and Keith Y.C. Goh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Clinical Microbiology.

In The Last Decade

Nicholas Wickham

35 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Wickham Australia 16 292 256 174 130 105 35 804
Renate Thalhammer Austria 14 393 1.3× 181 0.7× 199 1.1× 405 3.1× 88 0.8× 35 1.0k
Abraham Kornberg Israel 17 346 1.2× 189 0.7× 106 0.6× 80 0.6× 75 0.7× 54 925
Carlo L. Balduini Italy 20 674 2.3× 181 0.7× 248 1.4× 96 0.7× 36 0.3× 52 1.1k
Antonia Miñano Spain 18 498 1.7× 211 0.8× 111 0.6× 89 0.7× 38 0.4× 53 875
Shinsaku Hirosawa Japan 18 355 1.2× 308 1.2× 218 1.3× 178 1.4× 318 3.0× 43 1.2k
J. A. McBride United States 15 300 1.0× 136 0.5× 171 1.0× 166 1.3× 235 2.2× 33 876
Mackenzie Bowman Canada 18 760 2.6× 462 1.8× 169 1.0× 166 1.3× 92 0.9× 45 1.4k
H Gerhartz Germany 12 261 0.9× 100 0.4× 112 0.6× 217 1.7× 90 0.9× 42 666
Mauricio Ocqueteau Chile 13 617 2.1× 352 1.4× 179 1.0× 214 1.6× 101 1.0× 33 933
Andres O. Soriano United States 9 363 1.2× 658 2.6× 47 0.3× 226 1.7× 62 0.6× 15 1.1k

Countries citing papers authored by Nicholas Wickham

Since Specialization
Citations

This map shows the geographic impact of Nicholas Wickham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Wickham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Wickham more than expected).

Fields of papers citing papers by Nicholas Wickham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Wickham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Wickham. The network helps show where Nicholas Wickham may publish in the future.

Co-authorship network of co-authors of Nicholas Wickham

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Wickham. A scholar is included among the top collaborators of Nicholas Wickham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Wickham. Nicholas Wickham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheah, Chan Y., Wojciech Jurczak, Masa Lasica, et al.. (2021). TG-1701 A selective bruton tyrosine kinase (btk) inhibitor, as monotherapy and in combination with ublituximab and umbralisib (u2) in chronic lymphocytic leukemia (cll) and lymphoma. HemaSphere. 286–286. 1 indexed citations
2.
Tam, Constantine S., Hang Quach, Andrew J. Nicol, et al.. (2017). BGB-3111 in Combination with Obinutuzumab in Patients with Chronic Lymphocytic Leukemia and Follicular Lymphoma. Blood. 130. 1745–1745. 1 indexed citations
3.
Singhal, Deepak, Monika Kutyna, Rakchha Chhetri, et al.. (2017). Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome. Haematologica. 102(12). 2021–2029. 39 indexed citations
4.
Hibbert, Peter, Natalie Hannaford, T. Hooper, et al.. (2016). Assessing the appropriateness of prevention and management of venous thromboembolism in Australia: a cross-sectional study. BMJ Open. 6(3). e008618–e008618. 17 indexed citations
5.
Wickham, Nicholas, et al.. (2013). Bisphosphonate-associated osteonecrosis of the external auditory canal. The Journal of Laryngology & Otology. 127(S2). S51–S53. 19 indexed citations
7.
Lickliter, Jason D., Nicholas Wood, L. R. Johnson, et al.. (2003). HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death. Leukemia. 17(11). 2074–2080. 61 indexed citations
8.
Pile, K, et al.. (2001). FRI0003 High dose chemotherapy without autologous stem cell reinfusion in the treatment of ra. Annals of the Rheumatic Diseases. 60. A446–A446. 1 indexed citations
9.
Su, Xinying, Nathalie Wong, Qi Cao, et al.. (1999). Chromosomal Aberrations During Progression of Chronic Myeloid Leukemia Identified by Cytogenetic and Molecular Cytogenetic Tools. Cancer Genetics and Cytogenetics. 108(1). 6–12. 12 indexed citations
10.
Chen, Sai‐Juan, Qi Cao, Xinying Su, et al.. (1998). Detection of Chromosome Over- and Underrepresentations in Hyperdiploid Acute Lymphoblastic Leukemia by Comparative Genomic Hybridization. Cancer Genetics and Cytogenetics. 103(1). 20–24. 21 indexed citations
11.
Ng, M. H., et al.. (1997). The spectrum of chronic lymphoproliferative disorders in Hong Kong. A prospective study. Leukemia. 11(11). 1964–1972. 9 indexed citations
12.
Goh, Keith Y.C., et al.. (1997). Haemostatic changes during surgery for primary brain tumours. Journal of Neurology Neurosurgery & Psychiatry. 63(3). 334–338. 61 indexed citations
13.
Mok, Tony, et al.. (1997). Fatal Penicillium citrinum pneumonia with pericarditis in a patient with acute leukemia. Journal of Clinical Microbiology. 35(10). 2654–2656. 50 indexed citations
14.
Yeo, Winnie, N Wong, John Chow, et al.. (1996). Small cell variant of Ki-1 lymphoma associated with myelofibrosis and a novel constitutional chromosomal translocation t(3;4) (q13;q12).. Journal of Clinical Pathology. 49(3). 259–262. 4 indexed citations
15.
Lolin, Yvette, John Chow, & Nicholas Wickham. (1996). Monoclonal Gammopathy of Unknown Significance and Malignant Paraproteinemia in Hong Kong. American Journal of Clinical Pathology. 106(4). 449–456. 18 indexed citations
16.
Joynt, Gavin M., Nicholas Wickham, R. J. Young, & Charles D. Gomersall. (1996). Upper airway obstruction caused by acquired inhibitor to factor VIII. Anaesthesia. 51(7). 689–691. 2 indexed citations
17.
Liew, C. T., et al.. (1995). Acute monoblastic leukaemia with conjunctival tumours. Clinical Oncology. 7(6). 405–406. 3 indexed citations
18.
Tooze, J. Adam, J. C. W. Marsh, Nicholas Wickham, et al.. (1993). Response of aplastic anaemia and scleroderma to cyclosporin. British Journal of Haematology. 85(4). 829–831. 7 indexed citations
19.
Schorer, Anna E., Nicholas Wickham, & Kathleen Watson. (1989). Lupus anticoagulant induces a selective defect in thrombin‐mediated endothelial prostacyclin release and platelet aggregation. British Journal of Haematology. 71(3). 399–407. 60 indexed citations
20.
Vercellotti, G M, et al.. (1989). Thrombin-Treated Endothelium Primes Neutrophil Functions: Inhibition by Platelet-Activating Factor Receptor Antagonists. Journal of Leukocyte Biology. 45(6). 483–490. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026